The following is a summary of “Incidence and reasons for discontinuation of anti-VEGF treatment in neovascular age-related macular degeneration,” published in the March 2025 issue of British Journal of Ophthalmology by Borrelli et al. Researchers conducted a retrospective study to examine the factors and frequency of interruptions in intravitreal treatment for individuals with neovascular age-related […]
The post Factors Influencing Anti-VEGF Discontinuation in Neovascular AMD first appeared on Physician’s Weekly.
